Fractyl Health Inc
NASDAQ:GUTS
Intrinsic Value
The intrinsic value of one GUTS stock under the Base Case scenario is 1.2 USD. Compared to the current market price of 1.74 USD, Fractyl Health Inc is Overvalued by 31%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Fractyl Health Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Fractyl Health Inc
Balance Sheet Decomposition
Fractyl Health Inc
Current Assets | 47m |
Cash & Short-Term Investments | 42.1m |
Other Current Assets | 4.9m |
Non-Current Assets | 36m |
PP&E | 31.2m |
Other Non-Current Assets | 4.8m |
Free Cash Flow Analysis
Fractyl Health Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Fractyl Health Inc
Revenue
|
60k
USD
|
Cost of Revenue
|
-31k
USD
|
Gross Profit
|
29k
USD
|
Operating Expenses
|
-96.8m
USD
|
Operating Income
|
-96.7m
USD
|
Other Expenses
|
7.6m
USD
|
Net Income
|
-89.1m
USD
|
GUTS Profitability Score
Profitability Due Diligence
Fractyl Health Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Fractyl Health Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
GUTS Solvency Score
Solvency Due Diligence
Fractyl Health Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Fractyl Health Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GUTS Price Targets Summary
Fractyl Health Inc
According to Wall Street analysts, the average 1-year price target for GUTS is 9.52 USD with a low forecast of 6.06 USD and a high forecast of 12.6 USD.
Dividends
Current shareholder yield for GUTS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one GUTS stock under the Base Case scenario is 1.2 USD.
Compared to the current market price of 1.74 USD, Fractyl Health Inc is Overvalued by 31%.